Overview

Maternal Hyperoxygenation in Congenital Heart Disease

Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
A pilot study investigating the safety and feasibility of chronic maternal hyperoxygenation in the setting of fetal congenital heart disease
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
The Hospital for Sick Children